Zimmer Biomet Share Price (NYSE: ZBH)

$107.7

▲

3.28

(3.14%)

Last updated on August 23, 2025 at 1:29 AM IST

$₹

Check the interactive Zimmer Biomet Stock chart to analyse performance

Zimmer Biomet stock performance

as on August 23, 2025 at 1:29 AM IST

Today's Low:$105.01
Today's High:$107.72
$107.70
2.5%
Downside
Day's Volatility :2.52%
Upside
0.02%
52 Weeks Low:$89.22
52 Weeks High:$116.71
$107.70
17.16%
Downside
52 Weeks Volatility :23.55%
Upside
7.72%

Zimmer Biomet Stock Returns

Period	Zimmer Biomet Holdings, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	14.32%	6.0%	0.0%
6 Months	1.62%	-5.6%	0.0%
1 Year	-6.39%	-11.1%	0.0%
3 Years	-1.82%	6.8%	-7.8%

Zimmer Biomet Holdings, Inc. Key Stats

Check Zimmer Biomet key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$104.42
Open	$105.01
Today's High	$107.72
Today's Low	$105.01
Market Capitalization	$20.7B
Today's Volume	$1.1M
52 Week High	$116.71
52 Week Low	$89.22
Revenue TTM	$7.8B
EBITDA	$2.6B
Earnings Per Share (EPS)	$4.1
PE Ratio	25.47
Dividend Yield	0.91%
Profit Margin	10.51%
Quarterly Earnings Growth YOY	-0.35%
Return On Equity TTM	6.53%

Stock Returns calculator for Zimmer Biomet Stock including INR - Dollar returns

The Zimmer Biomet stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Zimmer Biomet investment value today

Current value as on today

₹97,927

Returns

₹2,073

(-2.07%)

Returns from Zimmer Biomet Stock

₹6,389 (-6.39%)

Dollar Returns*

₹4,316 (+4.32%)

Indian investors sentiment towards Zimmer Biomet Stock

44%

Period: Jul 23, 2025 to Aug 22, 2025. Change in 30 Days versus previous period

Search interest for Zimmer Biomet Stock from India on INDmoney has increased by 44% in the last 30 days, reflecting an upward trend in search activity.

Indian Mutual Funds that invest in Zimmer Biomet Stock

Name	Shares Held	Change in Shares	% of Assets
ICICI Prudential US Bluechip Equity Fund Direct Plan Growth	93999	-16053.15	2.32%
Motilal Oswal S&P 500 Index Fund Direct Growth	1599	-5.85	0.03%

Global Institutional Holdings in Zimmer Biomet Holdings, Inc.

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
11.74%
Dodge & Cox
11.15%
BlackRock Inc
8.05%
T. Rowe Price Associates, Inc.
7.47%
State Street Corp
4.42%
Capital Research & Mgmt Co - Division 3
3.42%

Analyst Recommendation on Zimmer Biomet Stock

Rating

Trend

Hold

37%Buy

56%Hold

6%Sell

Based on 32 Wall street analysts offering stock ratings for Zimmer Biomet(by analysts ranked 0 to 5 stars)

Zimmer Biomet Share Price Target

What analysts predicted

Upside of 2.99%

Target:

$110.92

Current:

$107.70

Zimmer Biomet share price target is $110.92, a slight Upside of 2.99% compared to current price of $107.70 as per analysts' prediction.

Zimmer Biomet Stock Insights

Price Movement
In the last 1 month, ZBH stock has moved up by 10.7%
Increasing Revenue
Revenue is up for the last 2 quarters, 1.90B → 2.07B (in $), with an average increase of 8.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 4 quarters, 249.1M → 152.8M (in $), with an average decrease of 14.6% per quarter
ZBH vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 34.1% return, outperforming this stock by 40.5%
ZBH vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 159.8% return, outperforming this stock by 161.3%
Price to Sales
ForZBH every $1 of sales, investors are willing to pay $2.7, whereas for Boston Scientific Corp., the investors are paying $8.5 for every $1 of sales.

Zimmer Biomet Holdings, Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$8.0B	↑ 0.62%
Net Income	$1.1B	↓ 398.42%
Net Profit Margin	14.18%	↑ 18.96%

	FY20	Y/Y Change
Revenue	$7.0B	↓ 12.0%
Net Income	$-137.4M	↓ 112.14%
Net Profit Margin	-1.96%	↓ 16.14%

	FY21	Y/Y Change
Revenue	$6.8B	↓ 2.81%
Net Income	$401.6M	↓ 392.29%
Net Profit Margin	5.88%	↑ 7.84%

	FY22	Y/Y Change
Revenue	$6.9B	↑ 1.65%
Net Income	$231.4M	↓ 42.38%
Net Profit Margin	3.33%	↓ 2.55%

	FY23	Y/Y Change
Revenue	$7.4B	↑ 6.55%
Net Income	$1.0B	↑ 342.52%
Net Profit Margin	13.85%	↑ 10.52%

	FY24	Y/Y Change
Revenue	$7.7B	↑ 3.85%
Net Income	$903.8M	↓ 11.74%
Net Profit Margin	11.77%	↓ 2.08%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$1.9B	↓ 2.62%
Net Income	$172.4M	↓ 58.87%
Net Profit Margin	9.13%	↓ 12.48%

	Q2 FY24	Q/Q Change
Revenue	$1.9B	↑ 2.79%
Net Income	$242.8M	↑ 40.84%
Net Profit Margin	12.5%	↑ 3.37%

	Q3 FY24	Q/Q Change
Revenue	$1.8B	↓ 6.07%
Net Income	$249.1M	↑ 2.59%
Net Profit Margin	13.66%	↑ 1.16%

	Q4 FY24	Q/Q Change
Revenue	$2.0B	↑ 10.91%
Net Income	$239.5M	↓ 3.85%
Net Profit Margin	11.84%	↓ 1.82%

	Q1 FY25	Q/Q Change
Revenue	$1.9B	↓ 5.64%
Net Income	$182.0M	↓ 24.01%
Net Profit Margin	9.53%	↓ 2.31%

	Q2 FY25	Q/Q Change
Revenue	$2.1B	↑ 8.81%
Net Income	$152.8M	↓ 16.04%
Net Profit Margin	7.36%	↓ 2.17%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$5.7B	↑ 1.21%

	FY20	Y/Y Change
Profit	$4.9B	↓ 14.55%

	FY21	Y/Y Change
Profit	$4.9B	↓ 0.6%

	FY22	Y/Y Change
Profit	$4.9B	↑ 1.1%

	FY23	Y/Y Change
Profit	$5.3B	↑ 7.93%

	FY24	Y/Y Change
Profit	$5.5B	↑ 3.33%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$1.4B	↓ 1.74%

	Q2 FY24	Q/Q Change
Profit	$1.4B	↑ 0.84%

	Q3 FY24	Q/Q Change
Profit	$1.3B	↓ 7.4%

	Q4 FY24	Q/Q Change
Profit	$1.4B	↑ 11.74%

	Q1 FY25	Q/Q Change
Profit	$1.4B	↓ 5.37%

	Q2 FY25	Q/Q Change
Profit	$1.3B	↓ 3.6%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$1.6B	↓ 9.25%
Investing Cash Flow	$-729.3M	↑ 75.06%
Financing Cash Flow	$-779.9M	↓ 40.11%

	FY20	Y/Y Change
Operating Cash Flow	$1.2B	↓ 24.04%
Investing Cash Flow	$-613.8M	↓ 15.84%
Financing Cash Flow	$-421.8M	↓ 45.92%

	FY21	Y/Y Change
Operating Cash Flow	$1.5B	↑ 24.47%
Investing Cash Flow	$-503.6M	↓ 17.95%
Financing Cash Flow	$-1.3B	↑ 209.63%

	FY22	Y/Y Change
Operating Cash Flow	$1.3B	↓ 14.31%
Investing Cash Flow	$-529.2M	↑ 5.08%
Financing Cash Flow	$-843.8M	↓ 35.39%

	FY23	Y/Y Change
Operating Cash Flow	$1.6B	↑ 23.11%
Investing Cash Flow	$-778.9M	↑ 47.18%
Financing Cash Flow	$-763.5M	↓ 9.52%

	FY24	Y/Y Change
Operating Cash Flow	$1.5B	↓ 5.2%
Investing Cash Flow	$-888.1M	↑ 14.02%
Financing Cash Flow	$-484.5M	↓ 36.54%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$228.0M	↓ 61.25%
Investing Cash Flow	$-195.0M	↓ 11.68%
Financing Cash Flow	$-50.1M	↓ 80.07%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$369.4M	↑ 62.02%
Investing Cash Flow	$-247.0M	↑ 26.67%
Financing Cash Flow	$-91.9M	↑ 83.43%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$395.7M	↑ 7.12%
Investing Cash Flow	$-154.9M	↓ 37.29%
Financing Cash Flow	$-101.9M	↑ 10.88%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$506.3M	↑ 27.95%
Investing Cash Flow	$-291.2M	↑ 87.99%
Financing Cash Flow	$-240.6M	↑ 136.11%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$382.8M	↓ 24.39%
Investing Cash Flow	$-106.0M	↓ 63.6%
Financing Cash Flow	$575.4M	↓ 339.15%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$378.2M	↓ 1.2%
Investing Cash Flow	$-1.4B	↑ 1206.04%
Financing Cash Flow	$163.8M	↓ 71.53%

Zimmer Biomet Technicals Summary

Sell

Neutral

Buy

Zimmer Biomet is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Zimmer Biomet Holdings, Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Zimmer Biomet Holdings, Inc.	11.18%	1.62%	-6.39%	-1.82%	-21.28%
Medtronic Plc	0.43%	2.83%	4.95%	3.85%	-7.4%
Edwards Lifesciences Corp.	7.86%	12.37%	15.35%	-13.9%	3.87%
Boston Scientific Corp.	-0.06%	1.69%	34.08%	157.96%	172.6%
Stryker Corporation	-0.64%	1.6%	11.55%	85.46%	108.86%
Abbott Laboratories	5.51%	-1.77%	17.63%	25.72%	30.74%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Zimmer Biomet Holdings, Inc.	25.47	25.47	1.36	8.14	0.07	0.04	0.01	63.29
Medtronic Plc	25.17	25.17	2.19	5.46	0.1	0.04	0.03	37.46
Edwards Lifesciences Corp.	33.96	33.96	4.86	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	62.63	62.63	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.04	51.04	2.23	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.56	16.56	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Zimmer Biomet Holdings, Inc.	Hold	$20.7B	-21.28%	25.47	10.51%
Medtronic Plc	Buy	$116.7B	-7.4%	25.17	13.63%
Edwards Lifesciences Corp.	Buy	$47.6B	3.87%	33.96	72.96%
Boston Scientific Corp.	Buy	$155.9B	172.6%	62.63	13.55%
Stryker Corporation	Buy	$147.1B	108.86%	51.04	12.25%
Abbott Laboratories	Buy	$229.7B	30.74%	16.56	32.43%

Zimmer Biomet Dividend announcements

Zimmer Biomet Dividends June, 2025
In the quarter ending June,2025. Zimmer Biomet has declared dividend of $0.24

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Organization	Zimmer Biomet
Employees	17000
CEO	Mr. Ivan Tornos
Industry	Health Technology

Key Management of Zimmer Biomet Holdings, Inc.

Name	Title
Mr. Ivan Tornos	President, CEO & Chairman of the Board
Mr. Suketu P. Upadhyay	CFO and Executive VP of Finance, Operations & Supply Chain
Mr. Sang Yi	Group President of Asia Pacific
Mr. Wilfred van Zuilen	Group President of Europe, Middle East & Africa
Mr. Paul A. Stellato	VP, Controller & Chief Accounting Officer
Mr. Shaun Braun	Senior VP & Chief Information and Technology Officer
Mr. David M. DeMartino	Senior Vice President of Investor Relations
Mr. Chad F. Phipps J.D.	Senior VP, General Counsel & Secretary
Ms. Angela Main	Senior VP, Global Chief Compliance Officer & Associate General Counsel of Asia Pacific
Ms. Kristen Cardillo	Senior VP & Chief Communications Officer

Important FAQs about investing in ZBH Stock from India :

What is Zimmer Biomet share price today?

Zimmer Biomet share price today is $107.70 as on August 23, 2025 at 1:29 AM IST at the close of the market. Zimmer Biomet share today touched a day high of $107.72 and a low of $105.01.

What is the 52 week high and 52 week low for Zimmer Biomet share?

Zimmer Biomet share touched a 52 week high of $116.71 and a 52 week low of $89.22. Zimmer Biomet stock price today i.e. August 23, 2025 at 1:29 AM IST is closed at $107.70, lower by 7.72% versus the 52 week high.

How to invest in Zimmer Biomet Stock (ZBH) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Zimmer Biomet on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Zimmer Biomet Shares that will get you 0.0139 shares as per Zimmer Biomet share price of $107.70 per share as on August 23, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Zimmer Biomet Stock (ZBH) from India?

Indian investors can start investing in Zimmer Biomet (ZBH) shares with as little as ₹87.521 or $1 (as of August 23, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Zimmer Biomet stock (as per the Rupee-Dollar exchange rate as on August 23, 2025). Based on Zimmer Biomet share’s latest price of $107.70 as on August 23, 2025 at 1:29 AM IST, you will get 0.0929 shares of Zimmer Biomet. Learn more about fractional shares .

What are the returns that Zimmer Biomet has given to Indian investors in the last 5 years?

Zimmer Biomet stock has given -21.28% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?